You are using an older browser version. Please use a supported version for the best MSN experience.

Coronavirus: Russia agrees to produce Sputnik V vaccine in India logo 2020-11-27 Richard Connor
a close up of a bottle © Provided by

Russia's sovereign wealth fund and the Indian pharmaceutical company Hetero agreed to produce more than 100 million doses per year in India of the Sputnik V vaccine, according to a statement on Friday.

The Russian Direct Investment Fund (RDIF), which has been backing the vaccine and marketing it globally, plans to start production at the beginning of 2021.

With final-phase trials ongoing, Indian drugmaker Dr Reddy's Laboratories Ltd. said it expected late-stage trials to be finalized as soon as March 2021.

Author: Richard Connor

More from Deutsche Welle ZA

image beaconimage beaconimage beacon